Overview

A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers

Status:
Not yet recruiting

Trial end date:
2022-02-01

Target enrollment:

Participant gender:

Summary

This is a randomized, open-label, single-dose, five-period crossover, relative bioavailability study to evaluate tadalafil gummy 10mg and tadalafil oral tablets 10mg in healthy volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Seattle Gummy Company

Treatments:

Tadalafil